Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 42


Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome.

Jensen AD, Uhl M, Chaudhri N, Herfarth KK, Debus J, Roeder F.

Radiat Oncol. 2015 May 6;10:109. doi: 10.1186/s13014-015-0414-8.


Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.

Jensen AD, Poulakis M, Nikoghosyan AV, Chaudhri N, Uhl M, Münter MW, Herfarth KK, Debus J.

Radiother Oncol. 2015 Feb;114(2):182-8. doi: 10.1016/j.radonc.2015.01.002. Epub 2015 Jan 29.


High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results.

Uhl M, Mattke M, Welzel T, Oelmann J, Habl G, Jensen AD, Ellerbrock M, Haberer T, Herfarth KK, Debus J.

Cancer. 2014 May 15;120(10):1579-85. doi: 10.1002/cncr.28606. Epub 2014 Feb 5.


Single-dose radiosurgical treatment for hepatic metastases--therapeutic outcome of 138 treated lesions from a single institution.

Habermehl D, Herfarth KK, Bermejo JL, Hof H, Rieken S, Kuhn S, Welzel T, Debus J, Combs SE.

Radiat Oncol. 2013 Jul 9;8:175. doi: 10.1186/1748-717X-8-175.


A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.

Song DY, Herfarth KK, Uhl M, Eble MJ, Pinkawa M, van Triest B, Kalisvaart R, Weber DC, Miralbell R, Deweese TL, Ford EC.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):81-7. doi: 10.1016/j.ijrobp.2012.12.019. Epub 2013 Feb 13.


IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.

Jensen AD, Nikoghosyan AV, Lossner K, Herfarth KK, Debus J, Münter MW.

BMC Cancer. 2012 May 2;12:163. doi: 10.1186/1471-2407-12-163.


Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.

Jensen AD, Nikoghosyan AV, Ecker S, Ellerbrock M, Debus J, Herfarth KK, Münter MW.

Radiat Oncol. 2011 Nov 2;6:149. doi: 10.1186/1748-717X-6-149.


Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial.

Jensen AD, Münter MW, Bischoff HG, Haselmann R, Haberkorn U, Huber PE, Thomas M, Debus J, Herfarth KK.

Cancer. 2011 Jul 1;117(13):2986-94. doi: 10.1002/cncr.25888. Epub 2011 Jan 24.


[Radiotherapy of hepatic metastases].

Combs SE, Herfarth KK, Habermehl D, Debus J.

Chirurg. 2010 Jun;81(6):526-32. doi: 10.1007/s00104-010-1889-3. Review. German.


Comparison of arc-modulated cone beam therapy and helical tomotherapy for three different types of cancer.

Ulrich S, Sterzing F, Nill S, Schubert K, Herfarth KK, Debus J, Oelfke U.

Med Phys. 2009 Oct;36(10):4702-10.


Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study.

Rochet N, Sterzing F, Jensen AD, Dinkel J, Herfarth KK, Schubert K, Eichbaum MH, Schneeweiss A, Sohn C, Debus J, Harms W.

Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1382-9. doi: 10.1016/j.ijrobp.2009.03.061. Epub 2009 Jul 21.


Reirradiation of multiple brain metastases with helical tomotherapy. A multifocal simultaneous integrated boost for eight or more lesions.

Sterzing F, Welzel T, Sroka-Perez G, Schubert K, Debus J, Herfarth KK.

Strahlenther Onkol. 2009 Feb;185(2):89-93. doi: 10.1007/s00066-009-1971-2. Epub 2009 Feb 25.


Sarcomatoid sarcoma of the scalp - helical tomotherapy as a new radiotherapy option.

Sterzing F, Neuhof D, Stroebel P, Debus J, Herfarth KK.

Eur J Dermatol. 2008 Nov-Dec;18(6):731-2. doi: 10.1684/ejd.2008.0539. No abstract available.


[What is the impact of new radiotherapy techniques?].

Sterzing F, Münter MW, Jensen AD, Stoiber EM, Huber P, Herfarth KK, Debus J.

HNO. 2008 Jun;56(6):585-93. doi: 10.1007/s00106-008-1719-9. Review. German.


Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.

Sterzing F, Sroka-Perez G, Schubert K, Münter MW, Thieke C, Huber P, Debus J, Herfarth KK.

Radiother Oncol. 2008 Feb;86(2):251-7. doi: 10.1016/j.radonc.2007.12.010. Epub 2008 Jan 18.


Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.

Münter MW, Hoffner S, Hof H, Herfarth KK, Haberkorn U, Rudat V, Huber P, Debus J, Karger CP.

Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):651-9. Epub 2006 Dec 15.


[Advances in radio-oncology. From precision radiotherapy with photons to ion therapy with protons and carbon ions].

Combs SE, Schulz-Ertner D, Herfarth KK, Krempien R, Debus J.

Chirurg. 2006 Dec;77(12):1126-32. Review. German.


Absence of tissue reaction after focal high-dose irradiation of rabbit liver.

Herfarth KK, Münter MW, Groene HJ, Delorme S, Peschke P, Debus J.

Acta Oncol. 2006;45(7):865-9.


Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518).

Jensen AD, Münter MW, Bischoff H, Haselmann R, Timke C, Krempien R, Sterzing F, Nill S, Heeger S, Hoess A, Haberkorn U, Huber PE, Steins M, Thomas M, Debus J, Herfarth KK.

BMC Cancer. 2006 May 8;6:122.


Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].

Krempien R, Muenter MW, Huber PE, Nill S, Friess H, Timke C, Didinger B, Buechler P, Heeger S, Herfarth KK, Abdollahi A, Buchler MW, Debus J.

BMC Cancer. 2005 Oct 11;5:131.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk